Cupid Q4FY26 record results, shares slide 5% on cost fears

Cupid shares fall despite record quarter

Cupid Ltd shares fell more than 5% in Tuesday’s trade even after the company reported what it called its strongest-ever quarterly performance for Q4FY26. On the NSE, the stock declined 5.04% or Rs 6.09 to Rs 114.75. The drop came even as the stock remained up more than 500% over the last one year, highlighting how quickly sentiment can shift after a sharp run-up. Investor focus moved away from the headline earnings beat to near-term risks around input costs and supply. In particular, the market is watching crude-linked raw material availability and pricing for condom and healthcare product manufacturing.

What triggered the sell-off on Tuesday

The immediate pressure on the stock was linked to concerns over disruptions associated with the West Asia conflict. Investors are assessing the possible impact on crude-based raw materials that feed into condoms and related healthcare products. The risk is not limited to one company, but Cupid’s premium valuation and recent strong price performance can amplify reactions to any uncertainty. The sell-off also came against a backdrop of profit booking, a pattern that has appeared at different points during the stock’s multibagger rally.

Q4FY26 numbers: revenue, profit and margins

For the quarter ended March 31, 2026, Cupid reported a sharp rise in profitability and revenue. Net profit jumped nearly threefold year-on-year to Rs 36.3 crore from Rs 11.5 crore. Revenue more than doubled to Rs 120 crore from Rs 56.5 crore. EBITDA rose to Rs 37.6 crore from Rs 13.5 crore, and the EBITDA margin expanded to 31.3% from 23.9%. The company’s Q4 performance also reinforced the improved operating leverage it has been reporting.

FY26 delivery versus guidance

Cupid said it surpassed its FY26 guidance of Rs 335 crore in revenue and Rs 100 crore in net profit. The company attributed the performance to strong execution, sustained demand momentum, and traction across key business segments. It also cited scale-up across business verticals and improved operating leverage. Management commentary pointed to continued traction in both domestic and international markets. Cupid added that the order pipeline remained robust across global institutional agencies, government procurement programmes, and FMCG channels.

Segment mix: condoms still lead, FMCG growing

Male condoms remained the largest contributor to revenue in FY26 at around Rs 181.11 crore. Female condoms contributed nearly Rs 60.72 crore. Newly launched FMCG products generated around Rs 84.26 crore during the year, a meaningful contribution for a newer vertical. The company also said its IVD kits and personal lubricant segment contributed about Rs 24.97 crore in FY26. Cupid positioned this spread as evidence that its portfolio across healthcare, wellness, diagnostics, and FMCG is strengthening the overall business mix.

Supply disruption risk: Iran conflict and crude-linked inputs

The raw material discussion intensified amid mounting global supply disruptions linked to the Iran conflict. The article cited Karex, the world’s largest condom manufacturer, saying last month it may raise prices by up to 30% or more if the conflict continues to disrupt raw material supplies. Karex chief executive Goh Miah Kiat said production costs had risen sharply after disruptions in global oil supply chains, following Iran’s threat of action in the Strait of Hormuz in response to US and Israeli airstrikes. For Cupid, the concern is how quickly crude-based input prices could move and whether supply reliability changes in a way that pressures costs.

Valuation overhang: “priced for perfection”

Even as earnings improved, valuation concerns continued to weigh on sentiment. Nitant Darekar, Research Analyst at Bonanza, said Cupid is priced for perfection with a TTM P/E near 200X and 43X book value, leaving zero margin for slippage in an uncertain global environment. He advised existing investors to book partial profits and hold the rest, while fresh buyers may be better off waiting for a healthier correction. Peer comparison data on the NSE showed companies such as Procter & Gamble Hygiene and Health Care, Gillette India, Emami, Honasa Consumer and Bajaj Consumer Care trading at significantly lower valuation multiples.

Technical levels traders are watching

Virat Jagad, Sr. Technical Research Analyst at Bonanza, said the stock saw a sharp correction after facing strong resistance near the 130-133 zone, indicating profit booking following the recent breakout rally. He added that the stock slipped below its short-term moving average and RSI dropped near the 40 mark, reflecting weakening near-term momentum. He said the broader trend remains positive as long as the stock sustains above the key support zone of 104-100, where buying interest may re-emerge. Immediate resistance was placed around 118-120, followed by 130. Jagad said if the stock stabilises above 120, a move toward 140-145 can be expected over the medium term, while a breakdown below 100 may weaken sentiment further.

Earlier volatility: ASM action and profit booking context

Separately, earlier reporting in January 2026 highlighted how regulatory curbs can interact with profit booking in high-momentum small caps. Cupid shares fell 20% for a second straight session on January 5, 2026, after a 550% rally in 2025, and were placed under the Additional Surveillance Measure (ASM) Stage 1 framework. That framework involved 100% margin requirements on a T+3 basis to curb volatility. On that day, the stock hit a one-month low of Rs 337.10 before recovering and closing at Rs 389. Analysts at the time advised caution and suggested the stock needed stabilisation and consolidation before new positions.

Key numbers at a glance

Why the episode matters for investors

The price action shows how quickly the market can shift from celebrating results to reassessing risk when a stock is valued for high expectations. Cupid’s Q4FY26 performance and FY26 segment mix indicate strong momentum, but the discussion has moved to input-cost sensitivity and supply chain uncertainty linked to crude and shipping routes. At the same time, the valuation multiples cited by analysts mean investors may demand consistent execution with limited room for disappointment. Technically, traders are also watching whether support levels hold after the post-results weakness.

Conclusion

Cupid’s record Q4FY26 results were not enough to prevent a sharp one-day decline as investors weighed West Asia-linked raw material risk, premium valuations, and near-term technical signals. The next set of cues will likely come from management commentary on input costs and supply, alongside how the stock trades around the 104-100 support zone and the 118-120 resistance area cited by analysts.